SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-08-006303
Filing Date
2008-08-04
Accepted
2008-08-04 16:05:25
Documents
2
Period of Report
2008-07-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 LIGAND PHARMACEUTICALS INCORPORATED 8-K a5747592.htm 8-K 18356
2 EXHIBIT 99.1 a5747592-ex991.htm EX-99.1 4700
  Complete submission text file 0001157523-08-006303.txt   24686
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 08988155
SIC: 2834 Pharmaceutical Preparations